SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Cromos offers free clinical trials to cash-strapped small and mid-sized pharmas

Cromos Pharma has launched a free or reduced cost trial model to help small and mid-sized drugmakers overcome the funding Catch-22 that can derail development efforts.

Cromos offers free clinical trials to cash-strapped pharmas

Undeterred by Ukrainian unrest, KCR acquires portfolio of clinical projects

European CRO KCR has acquired a portfolio of clinical projects from the Ukrainian CRO Axis Group thereby making the country the most important location for KCR in the region of the Commonwealth of Independent States (CIS).

WIL IT software deal speed up US FDA drug evaluations? Yes says Instem

Regulatory reviewers spend more time managing incoming data than on the drug evaluation process, says Instem which has inked a deal with WIL Research for its nonclinical IT systems.

Festive Flick

Happy Holidays 2014 from William Reed Business Media!

The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!

PPD partners with ERT to focus on big data collection

CROs Pharmaceutical Product Development (PPD) and ERT on Tuesday announced a strategic partnership to deliver ERT’s patient safety and efficacy endpoint data collection tools to help biopharma clients conduct clinical trials in a more efficient and cost-effective manner. 

Compound interest? US FDA sets up compounding pharmacy advisory committee

The US FDA has set up a committee to provide advice on scientific, technical and medical issues concerning drug compounding.

Spotlight

Medidata: Digital biomarkers are the future of clinical trials

Medidata: Prepare to embrace digital biomarkers in trials or lose competitiveness

The advent of Big Data in clinical trials will mean companies not using digital biomarkers are unlikely...

More details on Cetero/PRACS implosion come to light

More details on Cetero/PRACS implosion come to light

Lachman Consultants has revealed more of the story behind the decline of the now bankrupt CRO Cetero/PRACS,...

UK Hospitals to play part in Gov efforts to speed clinical trial process

UK Hospitals to play part in Gov efforts to speed clinical trial process

UK life sciences minister George Freeman wants hospitals to play more of a role in clinical trials...

Quintiles CEO: Innovation coming from CROs takes pressure off pharma
Dispatches from FT Global Pharmaceutical and Biotechnology conference, London

Quintiles CEO: Change in R&D paradigm must come from Pharma's boardrooms

Vertical integration is inhibiting pharma R&D innovation, according to Quintiles CEO Tom Pike who says executives must...

New Ricerca CEO remains positive as questions linger over company

New Ricerca CEO remains positive as questions linger over company

As questions continue to be raised over why Ricerca was on the brink of closure and laying...

'Killer experiments' and reimbursement are the keys to VC backing says Index

'Killer experiments' and reimbursement are the keys to VC backing says Index

Investors only back drug innovators because they have to according to Index Venture Management's Kevin Johnson, who...

Key Industry Events

 

Access all events listing

Our events, Events from partners...